NOWDiagnostics granted CE Mark for Rapid Syphilis Test

Written by Sophie Hefner

In The News

FDA approves NOWDiagnostics’ ADEXUSDx® hCG Test
NOWDiagnostics granted CE Mark for Rapid Syphilis Test
NEW Automation Capacity Yields 2M Tests/Month

Past Stories

NOWDiagnostics Announces Jim Haworth as Executive Chairman of the Board of Directors
American Pharmacists Association Foundation, NOWDiagnostics Launch Nationwide In-Pharmacy Real-Time COVID-19 Antibody Testing with Spike Protein-Targeted, Rapid ADEXUSDx® Test
ADEXUSDx® COVID-19 Antibody Test Receives FDA Emergency Use Authorization
University of Milan Study Finds Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Test has 100% Specificity
NWA's NOWDiagnostics Chosen as Endeavor Entrepreneur at 7th Virtual International Selection Panel
BARDA and NOWDiagnostics Partner to Develop Rapid COVID-19 Antibody Test for Use Point-of-Care and At-Home
ADEXUSDx® COVID-19 Test receives Conformité Européene (CE) mark approval
It’s Official! NOWDx acquires CELLMIC Reader Technology
Now Diagnostics’ Rapid Blood Pregnancy Test Receives Approval in Europe for Over-The-Counter Sales
NOWDiagnostics Honored as Finalist in the 2017 Medical Design Excellence Awards
NOWDiagnostics will provide tropical disease tests in Africa
NOWDiagnostics Inc. Acquires Canada’s ZBx Corporation
FDA approves NOWDiagnostics’ ADEXUSDx® hCG Test